Tilray Brands, Inc. (TLRY.TO)

2.000.05 (2.56%)

Tilray Brands, Inc. (TLRY.TO) stock comprehensive Forecast and Price Target with Analyst Ratings, Revenue Estimates, and complete financial and advanced discounted cashflow forecasts for up to 10 years.

High Bankruptcy RiskFair ValuationLow ProfitabilityAdequate Financial HealthModerate EfficiencyModerate GrowthLow QualityAdequate Dividend ProfileIndustry Rank: 44.14%Sector Rank: 55.17%

TSX - Healthcare - Drug Manufacturers - Specialty & Generic | Market Cap: 2.20B | Next Earnings Date: 9 Oct 2025

Day's Range

1.90 - 2.15

52-Week Range

0.48 - 2.54

Volume

9.88M / 3.06M (Avg.)

P/E Ratio | EPS

-0.59 | -3.40

Trending:

Analyst Consensus

Compare with Competitor

None WEED.TO ACB.TO TLRY OGI.TO CRON.TO

View analysts' price targets and recommendations, and compare them with competitors.

Analyst Price Target

No Data

No price target data available for this metric.

Analyst Recommendation

Hold

Equal to TLRY's analyst recommendation of Hold.

Financial Forecasts for May 2024

Select Date

May 2030 May 2029 May 2028 May 2027 May 2026 May 2025

Compare with Competitor

None WEED.TO ACB.TO TLRY

Analyze analyst forecasts for the company and compare them with competitors.

Estimated Revenue

1.07B

Increased from previous period

Low: 1.02B | High: 1.13B

Better than TLRY's estimated revenue of 784.96M.